Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Management of MDD
NCT06698666Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in major depressive disorder (MDD), sponsored by Ain Shams University. Started Oct 2022; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06698666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06698666.